We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
Biotage Launches the Isolera™ Dalton
Product News

Biotage Launches the Isolera™ Dalton

Biotage Launches the Isolera™ Dalton
Product News

Biotage Launches the Isolera™ Dalton


Want a FREE PDF version of This Product News?

Complete the form below and we will email you a PDF version of "Biotage Launches the Isolera™ Dalton"

First Name*
Last Name*
Email Address*
Country*
Company Type*
Job Function*
Would you like to receive further email communication from Technology Networks?

Technology Networks Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy

Microsaic Systems plc, welcomes the official launch by Biotage AB of the Isolera™ Dalton, a fully integrated system for Flash chromatography and mass identification incorporating Microsaic’s novel miniature mass spectrometer – the Microsaic MiD®.

The Isolera™ Dalton seamlessly integrates the Microsaic MiD® with Biotage’s flagship Flash purification system Isolera™ to enable a chemist to identify compounds by mass in real-time during Flash separation. By integrating separation with mass identification the system removes complex off-line analytical steps and can significantly increase throughput for the user.

Colin Jump, Chief Executive of Microsaic Systems, commented:

"One of Microsaic’s key strategic aims is to grow sales of our innovative products through OEM partnerships so today’s launch by Biotage of the Isolera™ Dalton incorporating our MiD® mass spectrometer represents an important milestone for the Company. The launch of the Isolera™ Dalton follows the announcement earlier this year of our second OEM agreement for the marketing and sale of the MiD® as a stand-alone instrument, demonstrating the excellent progress we are making towards delivering on our strategy. Discussions with further potential partners and customers are on-going, and convince us there is significant additional demand for our product across multiple application areas and formats, and we look forward to announcing further progress in due course.”

Advertisement